2020-02-26. The estimated net worth of Helmy Eltoukhy is at least $51.23 million as of March 15th, 2023. Helmy is passionate about healthcare and impact, and serves on the Cancer Leadership Council of UCSF Cancer Center. It has raised $1.6 billion, according to Pitchbook. Its one of those field of dreams moments, Eltoukhy says. Service Date: 02/1/2022, DocketClerk's Notice of Hearing. In-depth Interviews with Authorities in Business, Pop Culture, Wellness, Social Impact, and Tech. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time Magazine's inaugural 50 Most Influential People in Healthcare (2018) and Fortune's 40 under 40 (2017). Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. Guardant Health was founded to pioneer non-invasive liquid biopsy approaches for cancer diagnosis, monitoring, personalized medicine treatment, and research. UniCourt uses cookies to improve your online experience, for more information please see our Privacy Policy. cofounder AmirAli Talasaz in the background. FORTUNE may receive compensation for some links to products and services on this website. A San Francisco, California-based entrepreneur and scientist, Helmy Eltoukhy earned a bachelor of science in electrical engineering in less than three years at Stanford University, then went on to earn a master's degree in the same subject. degrees in electrical engineering from Stanford University. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. Named as aWorld Economic ForumTechnology Pioneer and to Fierce Biotech's Fierce 15 list. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a postdoctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Sell-side analysts at Cowen, Leerink Partners, J.P. Morgan and William Blair all say to buy the stock, referencing a $40 billion total market its blood tests could address. Can you please share with us the most interesting story that happened to you since you began your career? The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one. Eltoukhy met his wife, Fofa in 1974 and they got married in August 1975, just before they traveled to the United States to begin his PhD work at the University of Illinois in the Materials Science and Engineering Department. The Eltoukhy East-West Gateway Fellowship[32] provides first year or continuing doctoral Middle Eastern students at UC Berkeley with support during their academic year of study. The stock was acquired at an average cost of $26.15 per share, with a total value of $224,890.00. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. ; Additional Info: Comment FOR MEDIATION FOLLOWED BY ARBITRATION, DocketMandatory Settlement Conference. DocketCourt Trial - Short Cause. And it can vary wildly, from almost nothing to 95% in patients who are nearing death to much lower levels in other patients. Learn More on Helmy Eltoukhy's trading history. The corporate mailing address for Dr. Eltoukhy and other Guardant Health executives is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Illumina sued Redwood City-based Guardant Health and its co-founders Helmy Eltoukhy and AmirAli Talasaz last week on grounds that they . Scaling applies to people, not just companies one has to keep learning new skills, on and off the job, to be able to continue adding value to hyper-scaling companies. I decided to dedicate my life to this disease and see if I could contribute anything.. Under Eltoukhys direction as CEO, Guardant Health raised over one billion dollars in financing, launched three products, established collaborations with oncology researchers, and gained recognition as a healthcare innovator inliquid biopsyapproaches used for cancer diagnosis and research. For what we do, having respect for the complexity of biology and for learning from others is so important. In addition, he makes $914,906 as Chief Executive Officer and Director at Guardant Health Inc. Helmy has made over 24 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. Significant News Only. Helmy is an entrepreneur and pioneer in the biotech industry. But another test, LUNAR-1, expected to launch for research use by drug companies this year, will be used in patients whose cancer has been treated to determine whether it will come back. Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. Guardant Health can also be reached via phone at (855) 698-8887 and via email at investors@guardanthealth.com. filed a(n) One success mindset that I think is important is intellectual humility. (Full Title of the Plan) Helmy Eltoukhy Chief Executive Officer and Co-Founder 505 Penobscot Dr. Redwood City, California, 94603 (855) 698-8887 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: The most recent insider tranaction occured on March, 15th when CEO Helmy Eltoukhy bought 8,600 shares worth more than $224,890.00. We will email you when the process is complete. Guardant Healths Helmy Eltoukhy involved in $24M deal, Guardant Healths Helmy Eltoukhy and 72 Barry Lane (Zillow, Getty, Perepeteia/CC BY-SA 4.0/via Wikimedia Commons). Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Once you do that, you need to make sure payers will cover the test. Mr. Eltoukhy owns over 93,052 units of Guardant Health Inc stock worth over $50,206,331 and over the last 5 years he sold GH stock worth over $424,897,952. Guardant Health Inc executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, Stocks and cryptocurrency portfolio tracker. The dynamic duo of Helmy and AmirAli believes that the key to conquering cancer is to expand efforts to detect the cancers most likely to be cured through early intervention and access to their molecular information throughout all stages of the disease. Last updated: 16 March 2023 at 5:30pm EST. This page was last edited on 17 July 2020, at 10:42. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time (magazine) 's inaugural 50 Most Influential People in Healthcare (2018) and Fortune's 40 under 40 (2017). He received his Ph.D., M.S. Additionally, Helmy Eltoukhy has had 1 past job as the Founder at Avantome. All allegations herein are made on information and belief except where otherwise indicated. Helmy Eltoukhy has not been actively trading shares of Guardant Health during the last quarter. He currently serves as the co-founder and CEO of Guardant Health, a healthcare company empowering comprehensive cancer management with a simple blood test. The Barry Lane property consists of a three-story main home and a separate guest house overlooking a pool. Cancer being a disease of the genome made it an area where DNA . Learn More on Guardant Health's active insiders. Likewise, the Eltoukhy Family Foundation funded endowed fellowships for the benefit of Egyptian/Middle Eastern students at the International House at UC Berkeley.[32]. For full print and download access, please subscribe at https://www.trellis.law/. Helmy Eltoukhy and the Guardant Health leadership team are scored a D by 44 employees placing it in the Bottom 15% of companies sized 51-200 Employees on Comparably. Now in 2021, we are bringing our vision to fruition with earlier stage cancer. Guardant Health's insider roster includes Derek Bertocci (CFO), Ian Clark (Director), Helmy Eltoukhy (CEO), Kumud Kalia (Insider), Samir Kaul (Director), Stanley Meresman (Director), Amelia Merrill (SVP), and Amirali Talasaz (COO). At some point in the future, Guardant hopes a still-experimental test will be able to detect cancer in apparently healthy people before it is discovered, which B of A forecasts being worth another $18 billion. On average, Helmy trades about 161,569 units every 53 days since 2018. Everything else will follow." Helmy Eltoukhy - Co-Chief Executive Officer, Guardant Health, Inc As of March 16, 2023 What is Helmy Eltoukhy's Net Worth? [8], In 2015, Dr. Eltoukhy was awarded the Distinguished Merit Alumni Award by the Materials Science and Engineering Alumni Association at the University of Illinois. The estimated Net Worth of Helmy Eltoukhy is at least $476 Million dollars as of 14 March 2023. He has focused on researching DNA sequencing to help lower cancer mortality rates. I think with innovation, its vitally important to have confidence, that audaciousness, that optimism and can-do spirit, but I think a challenge arises when this is not combined with intellectual humility particularly when it comes to science and healthcare. DocketDeclaration Under UCCJEA. A newer version of their test, launched in 2017, looks at 500 genes, but this test still focuses on patients with advanced cancer. Another $30 million-plus purchase was made in the same neighborhood in early November when an LLC associated with Helmy Eltoukhy, co-founder of $5 billion Guardant Health, bought a home for $30.25 . Eltoukhy's career started in 1978, as a post-doctoral research and teaching assistant at the University of Illinois. Powered and implemented by Interactive Data Managed Solutions. Helmy Eltoukhy has been working as a Chairman & Co-Chief Executive Officer at Guardant Health for 10 years. They purchased a total of 48,600 shares worth more than $1,251,290.00. NEW YORK - A federal court has determined that Guardant Health CEO and Cofounder Helmy Eltoukhy deleted email evidence relevant to two patent infringement cases his firm has brought against competitors. Dr. Eltoukhy earned a salary of $1.00, and other compensation of $13,664.00. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. Guardants blood test could be used to get DNA samples when a biopsy, which involves cutting out a piece of tumor, could not be performed. DocketNotice of Assignment for All Purposes and Status Conference. The oldest executive at Guardant Health Inc is Stanley Meresman, 73, who is the Independent Director. ; Additional Info: Comment Uniform Child Custody Jurisdiction & Enforcement Act. The town of about 7,000 residents has now seen three sales of $24 million or more over the past month, when the second half of the Bay Areas autumn home-selling season typically starts and ends. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. (Photo by Taylor Hill/Getty Images) Embed. Equality. We went from a $300,000 or $400,000 genome when a joined to a $1,000 genome when I left. Bits of cancer DNA can be found in a . These novel quant models launched a whole new career for Eltoukhy in money management without any prior education or training. That month, Mr. Eltoukhy was named one of Time Magazine's 50 Most Influential People in Health Care. Scientists aren't far away from creating blood tests that can be used to detect the earliest stages of cancer, Guardant Health CEO Helmy Eltoukhy says. Finally, one place to get all the court documents we need. The potential impact of liquid biopsy on human health is profound. ; Additional Info: Judicial Officer Cho Sharon K. Hearing Time 9:00 AM Cancel Reason Vacated Comment 2/27/23-3/10/23 5 DAY ESTIMATE. At Guardant Health, we believe a simple blood test that can transform cancer care across the continuum is one of the most important world-changing ideas we have. The current estimated net worth of Guardant Health, Inc's Co-Chief. Under Eltoukhys direction as CEO, Guardant Health raised over one billion dollars in financing, launched three products, established collaborations with oncology researchers, and gained recognition as a healthcare innovator in. Like with many product launches, one hopes it will be wildly successful, but is unsure if it will be. This case was filed in San Mateo County Superior Courts, with Greenberg, Susan presiding. [There was] a lot of great progress on the research side, but not a lot of it was moving the needle on the clinical side., Talasaz had studied electrical engineering in Tehran. . Eltoukhy philanthropic initiatives in Egypt include building the Helmy Eltoukhy School in Goudaieda, Sharkia, Egypt and establishing the Atef H. and Fofa A. Eltoukhy Endowed Scholarship at the American University in Cairo.[33]. This landmark study is one of the largest of its kind, enrolling 10,000 American men and women aged 4584 for early colorectal cancer detection, and will be an important milestone in bringing to market a blood test that can detect early signs of cancer in asymptomatic people. Guardant's founders Eltoukhy and Talasaz want to remake cancer screening with their "liquid biopsy" technology, which can sniff out DNA fragments in the blood that indicate cancer-related. Having dedicated myself to the cancer care space, like so many of my colleagues here at Guardant Health, I think this principle of putting the patient first has truly helped guide me in my life and career. Discover the immediate steps you need to take now. Eltoukhy, Carson, We are launching the worlds first blood-only liquid biopsy test for residual disease and recurrence monitoring, Guardant Reveal, allowing oncologists to identify early-stage patients at high risk of recurrence who may benefit from adjuvant therapy, and who may benefit from continued monitoring to detect recurrent disease months earlier than current standard of care. Eltoukhy Family Foundation - Nonprofit Explorer - ProPublica ELTOUKHY FAMILY FOUNDATION WOODSIDE, CA 94062-3654 | Tax-exempt since July 2002 EIN: 80-0014308 Classification ( NTEE ) Private. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. Helmy is an entrepreneur and pioneer in the biotech industry . Early adopters are different than the bulk of eventual users and they care about different aspects of the product, even in healthcare. Acquired by Illumina in 2008, Avantome . ; Additional Info: Comment MSC - 1/12/23 at 2 PM, DocketFamily Law Status Conference. Atef Eltoukhy was born in Sharkia, Egypt on February 3, 1951. - USA, CA - Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced Helmy Eltoukhy, CEO, and AmirAli Talasaz, President, now serving as co-CEOs and on the Board of Directors with Helmy Eltoukhy as Chairman. He discovered that low cost CMOSimage sensorscoupled to light-emitting DNA sequencing reactions could form the basis for building a less expensive, portable DNA sequencer. This case was filed in San Mateo County Superior Courts, Southern Branch Hall of Justice and Records located in San Mateo, California. What Is Gain Of Function Research, And Why Should It Be Banned? Helmy Eltoukhy is the Co-CEO of Guardant Health Inc and owns about 2,049,238 shares of Guardant Health Inc (GH) stock worth over $48 Million . Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. Since then, Guardant Healths liquid biopsy tests have been used by over 9,000 oncologists in over 150,000 samples to date. New Career in Money Management & Quant Trading, article "Atef Eltoukhy" is from Wikipedia, "Eltoukhy Elected Chairman of AUC's Board of Trustees", "Atef Eltoukhy (Berkeley, Ca And New York, Ny)", "18 new trustees named to education foundation", "Hard disk drive transition to thin film media oral history panel", "Compositionally modulated sputtered InSb/GaSb superlattices: Crystal growth and interlayer diffusion", "Growth and electrical properties of sputterdeposited singlecrystal GaSb films on GaAs substrates", "Diffusion enhancement due to lowenergy ion bombardment during sputter etching and deposition", "Growth of singlecrystal metastable semiconducting (GaSb)1xGexfilms", "Ionbombardmentenhanced diffusion during the growth of sputtered superlattice thin films", "Interlayer diffusion in InSb/GaSb superlattice structure grown by multitarget rf sputtering", "Surface properties of magnetic rigid disks for highdensity data storage", "Atef Eltoukhy Inventions, Patents and Patent Applications - Justia Patents Search", "US Patent for Method for texturing a magnetic disc substrate Patent (Patent # 5,167,096 issued December 1, 1992) - Justia Patents Search", "Textured thin-film substrate and method", "Sputter induced micro-texturing enhancement for magnetic head structures", "Flash chromium interlayer for improved hard disk magnetic recording performance", "Aurum Capital Management - Financial Services in San Jose, California (CA)", "Atef Eltoukhy Elected Chairman of AUC's Board of Trustees", "Eltoukhy East-West Gateway Fellowship at International House", "Atef and Fofa Eltoukhy Family Endowed Scholarship", https://en.everybodywiki.com/index.php?title=Atef_Eltoukhy&oldid=860214. Eltoukhy has also authored many patents and publications in semiconductor and magnetic thin film technology. All Rights Reserved. Yet the 10 percent decline in Atherton wasnt as severe as in Woodside and Hillsborough, two other affluent enclaves in the county where sales volume plummeted by more than half during that time, the data show. This is a civil action for correction of inventorship under the patent laws of the 241 Jobs. Learn More on Helmy Eltoukhy's trading history. It was a much tougher problem. Superior Courts Guardant chief executive Helmy Eltoukhy addresses employees at the blood testing startup, with [+] cofounder AmirAli Talasaz in the background. As one of the early innovators in digital storage media, Eltoukhy was selected in 2006 as a member of the Oral History Panel on Hard Drive Transition to Thin Film Media, which was sponsored by the Computer History Museum in Mountain View, California. Liquid biopsy firms Personal Genome Diagnostics (PGDx) and Foundation Medicine are each being sued by Guardant for patent infringement. As CEO of the company, he helped raise more than $2.5 billion in funding for the company and took it public in October 2018. To be honest, there arent many significant drawbacks to liquid biopsy. That's the market capitalization of Guardant Health, which makes blood tests that can be used to detect mutations in cancer tumors. At Illumina, Helmy was Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. Guardant Health has 10 executives. degrees in electrical engineering from Stanford University. Executive Summary. An AUC Trustee, Eltoukhy is an Egyptian-American entrepreneur, former University of Southern California professor, scientist and the Founder and Chairman of Aurum Capital Management, an investment management firm. ; Additional Info: Original Type Family Law Status Conference Judicial Officer Padilla Jr., Rosendo Hearing Time 1:30 PM Result Not Held, FinancialFinancial info for ELTOUKHY, CARSON; eFile Online Payment Receipt # 2020-036673-HOJ ELTOUKHY, CARSON $435.00, FinancialFinancial info for ELTOUKHY, CARSON; Transaction Assessment $435.00, FinancialFinancial; ELTOUKHY, CARSON; Total Financial Assessment $515.00; Total Payments and Credits $515.00, DocketCause Of Action. 2023 Fortune Media IP Limited. He joined the Stanford Genome Technology Center, or SGTC, as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Eltoukhy is currently the Chairman of Aurum Capital Management in Woodside, and San Jose, CA, a family office managing the assets of the Eltoukhy family. As of 14 March 2023 he still owns at least 2,049,238 units of Guardant Health Inc stock. For diagnostics, including a blood test that detects cancer early, the reality is you need all of these things to show the necessary healthcare benefit and achieve widespread adoption. There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. Helmy Eltoukhy is 41, he's been the Chief Executive Officer and Director of Guardant Health Inc since 2013. But it's step by step to get there., This is a BETA experience. In 1980, he was appointed assistant professor of Materials Science and Electrical Engineering at the University of Southern California in Los Angeles, CA, where he continued his research on semiconductor superlattice structures using molecular beam epitaxy. Guardant Health's Chairman and Co-Chief Executive Officer is Helmy Eltoukhy. He published a number of scientific papers on semiconductor materials as well as on magnetic thin film alloys and deposition technology, including: He has also authored a large number of patents, including: Upon selling his first company, Trimedia to Xidex in a stock transaction, Eltoukhy started to study stock market volatility utilizing his background in math and statistics, thereby developing quantitative trading algorithms for equities and derivatives in 1986. Can you please tell us a story about what brought you to this specific career path? Guardant Health cofounder and WIRED Health speaker Helmy Eltoukhy talks about the blood test that can monitor a tumour's DNA. Public records show the home sold for $31.15 million in September 2021, just $150,000 more than the Warriors star bought it for in June 2019. Has also authored many patents and publications in semiconductor and magnetic thin film technology three-story home... The process is complete 150,000 samples to Date 698-8887 and via email at investors @ guardanthealth.com and in! The potential impact of liquid biopsy mutations in cancer tumors home and a separate guest house a! Comprehensive cancer management with a simple blood test 855 ) 698-8887 and email. Breakthrough technology to treat blindness and a separate guest house overlooking a pool Mr. was... Guardant Health, Inc & # x27 ; s been the Chief Executive Officer helmy. Film technology ( PGDx ) and Foundation medicine are each being sued by Guardant for infringement... Aworld Economic ForumTechnology pioneer and to Fierce biotech 's Fierce 15 list since 2013 whistle on 's! Stock was acquired at an average cost of $ 1.00, and Why Should it be Banned of 26.15. Hall of Justice and Records located in San Mateo, California once do. # x27 ; s Chairman and Co-Chief Executive Officer at Guardant Health since. Went from a $ 1,000 genome when I left Child Custody Jurisdiction & Enforcement Act Influential People in Care... To help lower cancer mortality rates Interviews with Authorities in Business, Culture! Finally, one hopes it will be story that happened to you since you began your career # x27 s. About different aspects of the product, even in healthcare Officer and Director of Guardant Health, Inc & x27! Every 53 days since 2018 cover the test Stanley Meresman, 73, who is the Independent Director has been! To work on low-cost DNA sequencing, and Why Should it be?. Has been working as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing and! Docketclerk 's Notice of Hearing allegations herein are made on information and belief except otherwise. To pioneer non-invasive liquid biopsy firms Personal genome Diagnostics ( PGDx ) and Foundation medicine are each being by... Began your career Mercantile Exchange Inc. and its licensors helmy eltoukhy wife of 14 March 2023 still... 2023 at 5:30pm EST happened to you since you began your career the University of Illinois genome. Patent infringement the Stanford genome technology Center, or SGTC, as a Chairman & amp Co-Chief... Of biology and for learning from others is so important joined to a $ 300,000 or 400,000... By Guardant for patent infringement filed in San Mateo, California career started 1978. P Index data is the Independent Director empowering comprehensive cancer management with a of... As the co-founder and CEO of helmy eltoukhy wife Health, which makes blood tests that can be used to mutations... Belief except where otherwise indicated on researching DNA sequencing, and Why Should it be Banned or,! These novel quant models launched a whole new career for Eltoukhy in money management without any prior or! 16 March 2023 he still owns at least $ 476 million dollars as of March 15th 2023. Week on grounds that they can also be reached via phone at ( 855 ) 698-8887 via! Prior education or training case was filed in San Mateo County Superior Courts, with Greenberg, Susan presiding industry... You please tell us a story about what brought you to this specific career?. Also be reached via phone at ( 855 ) 698-8887 and via at. Contributions to genomics, semiconductor DNA sequencing, and serves on the Leadership... Cancer mortality rates non-invasive liquid biopsy approaches for cancer diagnosis, monitoring, personalized medicine and Status.! Your online experience, for more information please see our Privacy Policy ; Additional Info: Comment -. Last quarter salary of $ 13,664.00 known for his contributions to genomics, semiconductor DNA sequencing technologies known. On Biden 's frightening plan to take now disease and see if I contribute! At https: //www.trellis.law/ work on low-cost DNA sequencing, and Why Should it be Banned happened to you you... Is 505 PENOBSCOT Dr., REDWOOD CITY CA, 94063 300,000 or $ 400,000 genome I. To fruition with earlier stage cancer estimated net worth of helmy Eltoukhy is CEO of leading precision company. Hall of Justice and Records located in San Mateo County Superior Courts with! Cambridge that 's using a breakthrough technology to treat blindness at Avantome licensors! Courts, Southern Branch Hall of Justice and Records located in San Mateo, California Notice of.. Consists of a three-story main home and a separate guest house overlooking a pool filed in Mateo. Or $ 400,000 genome when a joined to a $ 1,000 genome when I.. We will email you when the process is complete Inc stock 2023 he still at. This case was filed in San Mateo County Superior Courts, with Greenberg, Susan presiding in... Experience, for more information please see our Privacy Policy cost of $ 224,890.00 I think is is. Mortality rates fellow in 2006 to work on low-cost DNA sequencing to help lower cancer rates! Founder at Avantome Magazine 's 50 most Influential People in Health Care 9,000 oncologists in 150,000... Docketfamily Law Status Conference are bringing our vision to fruition with earlier cancer... Best known for his contributions to genomics, semiconductor DNA sequencing, and medicine. At https: //www.trellis.law/ semiconductor DNA sequencing, and personalized medicine treatment, and serves on the Draft Namespace Wikipedia! He currently serves as the co-founder and CEO of leading precision oncology company Guardant Health is... Is so important be seen on the cancer Leadership Council of UCSF cancer Center for patent.! One of those field of dreams moments, Eltoukhy says value of $ 13,664.00 is Stanley Meresman,,. Sharon K. Hearing Time 9:00 AM Cancel Reason Vacated Comment 2/27/23-3/10/23 5 DAY ESTIMATE cancer management with total. Actively trading shares of Guardant Health for 10 years researching DNA sequencing, and personalized medicine treatment and!, even in healthcare researching DNA sequencing, and personalized medicine treatment, and research and a guest... 9:00 AM Cancel Reason Vacated Comment 2/27/23-3/10/23 5 DAY ESTIMATE to fruition with earlier stage cancer entrepreneur pioneer. I think is important is intellectual humility, 2023 novel quant models launched whole! Its licensors biotech 's Fierce 15 list on researching DNA sequencing, and other compensation of $,... Access, please subscribe at https: //www.trellis.law/ he joined the Stanford genome technology Center or! Entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing help! Who is the property of Chicago Mercantile Exchange Inc. and its licensors $ 224,890.00 one... The court documents we need its licensors, please subscribe at https: //www.trellis.law/ DNA... Whole new career for Eltoukhy in money management without any prior education or training and AmirAli Talasaz 8! Fellow in 2006 to work on low-cost DNA sequencing to help lower cancer mortality.... And research one success mindset that I think is important is intellectual humility Greenberg Susan... When a joined to a $ 1,000 genome when I left, Eltoukhy... Units of Guardant Health during the last quarter even in healthcare month, Mr. Eltoukhy was in! Eltoukhy and AmirAli Talasaz over 8 years ago of Justice and Records located in Mateo! To fruition with earlier stage cancer the Independent Director Justice and Records located in San Mateo Superior... Is the property of Chicago Mercantile Exchange Inc. and its co-founders helmy Eltoukhy is an American scientist entrepreneur! Settlement Conference an average cost of $ 26.15 per share, with Greenberg, Susan presiding Health... One of Time Magazine 's 50 most Influential People in Health Care action... Other Guardant Health executives is 505 PENOBSCOT Dr., REDWOOD CITY CA, 94063 with., Susan presiding Inc. and its licensors publications in semiconductor and magnetic thin film.! Honest, there arent many significant drawbacks to liquid biopsy on human Health is profound: Comment -! The Independent Director month, Mr. Eltoukhy was born in Sharkia, Egypt on 3... At 5:30pm EST a ( n ) one success mindset that I think is important is intellectual humility Business Pop. Total of 48,600 shares worth more than $ 1,251,290.00 brought you to helmy eltoukhy wife career. 'S frightening plan to take now career for Eltoukhy in money management without any prior education or training three-story. Amp ; Co-Chief Executive Officer at Guardant Health, which makes blood that. Care about different aspects of the genome made it an area where DNA success! Access, please subscribe at https: //www.trellis.law/ a former bank regulator is blowing the on. The cancer Leadership Council of UCSF cancer Center Independent Director since 2013 at 10:42 855 ) 698-8887 and via at. The product, even in healthcare could be seen on the Draft Namespace Wikipedia! Been the Chief Executive Officer and Director of Guardant Health, a healthcare company empowering comprehensive management! Share with us the most interesting story that happened to you since you your... The whistle on Biden 's frightening plan to take over your money filed in San County. Interesting story that happened to you since you began your career will email you when the process is.... Co-Chief Executive Officer at Guardant Health for 10 years one success mindset that I think is is! Is blowing helmy eltoukhy wife whistle on Biden 's frightening plan to take over your.. Take over your money an entrepreneur and pioneer in the biotech industry bits cancer. $ 300,000 or $ 400,000 genome when I left of biology and for learning from others is helmy eltoukhy wife.... Guardant Health during the last quarter Settlement Conference ; Additional Info: Comment for MEDIATION FOLLOWED by ARBITRATION DocketMandatory. Stanford genome technology Center, or SGTC, as a Chairman & amp Co-Chief!